Lincoln Pharmaceuticals Limited — Board Meeting, 13-11-2025: Outcome of Board Meeting

Lincoln Pharma's Q2 FY26 consolidated Net Profit fell 24% YoY to Rs. 20.01 Cr. Half-year Net Profit was Rs. 47.71 Cr. Board approved Rs. 1.80/share dividend for FY24-25. Company targets Rs. 1,000 Cr revenue in 3 years with 15-18% annual growth, expanding globally.